Browse the evidence

Targeting energy expenditure through thermogenic pathways (such as UCP1, futile creatine, calcium, or lipid cycles) is a viable therapeutic strategy for promoting negative energy balance and sustaining weight loss, distinct from appetite suppression.

While lifestyle changes are foundational, they often fail long-term due to biological counter-regulation. Future treatments may focus on boosting energy expenditure through specific cellular mechanisms (like thermogenesis in fat or muscle) rather than just restricting calories. For now, understanding that your body fights weight loss through increased hunger and reduced expenditure is key to managing expectations.

Consumption of protein supplements by muscle builders significantly alters gut microbiome composition and fecal metabolome, specifically increasing the abundance of Lactobacillales and allantoin while decreasing nucleotide metabolism gene expression compared to non-supplement users.

If you use protein supplements, your gut bacteria and metabolites will look different than non-users, specifically with higher levels of Lactobacillales and allantoin. This is a normal adaptation to higher protein/purine intake and does not imply negative health effects in this population.

Moderate consumption of eggs (1-2 per day) is safe and potentially healthy for most individuals, provided they replace refined carbohydrates or unhealthy meats.

You can safely eat 1-2 eggs per day. They are a healthy source of protein and nutrients. Just make sure you are eating them as part of a balanced diet, not alongside refined carbohydrates or processed meats.

Zinc supplementation (50 mg oral zinc acetate, 2x/day for 14 weeks) improves insulin secretion specifically in individuals with the SLC30A8 rs13266634 CT/TT genotype, demonstrating a genotype-dependent response to micronutrient intervention.

If you are considering zinc supplementation for insulin resistance, check your SLC30A8 genotype first. If you carry the CT or TT variant of rs13266634, 50mg of zinc acetate twice daily for 14 weeks may significantly boost your fasting insulin levels. If you have the CC genotype, this specific intervention may not offer the same benefit.

High adherence to a Mediterranean diet improves inflammatory biomarkers (triglycerides, hsCRP) in individuals with the TNF rs1800629 GG genotype, demonstrating that dietary patterns can modulate genetic inflammation risk.

If you have the TNF rs1800629 GG genotype, you are genetically predisposed to higher inflammation and triglycerides. Adopting a Mediterranean diet for at least one year can significantly improve these markers, reducing your cardiovascular risk. This is a key example of how diet can counteract genetic inflammation.

Among obese individuals, frequent or daily alcohol consumption and extra salt intake are independent risk factors for metabolic syndrome, whereas physical inactivity and sugar-sweetened drink consumption do not show statistically significant associations.

If you are obese, managing your weight is crucial, but it is not the only lever. This research suggests that for obese individuals, cutting out daily alcohol and reducing extra salt at the table are critical, specific actions to lower metabolic syndrome risk, potentially more so than just increasing exercise or cutting sugary drinks in this specific demographic.

High dietary protein intake is not detrimental to bone health and may support bone microarchitecture and strength, particularly from animal and dairy sources.

You do not need to limit protein for the sake of your bones. High protein intake, especially from dairy and animal sources, is associated with stronger bone structure. Ensure adequate calcium and vitamin D, but do not fear protein.

Hormonal contraceptive (HC) use is associated with a lower likelihood of experiencing menstrual cycle symptoms, specifically uterine cramps, in resistance-trained athletes.

If you are a resistance-trained athlete experiencing severe menstrual cramps, hormonal contraceptives (particularly combined oral pills) are statistically associated with a reduction in these symptoms. However, be aware that nearly half of users report unwanted side effects from the contraceptives themselves. Consult a healthcare provider to weigh the benefit of reduced cramping against the risk of HC side effects.

Competitive-level resistance-trained athletes are significantly less likely to alter their training load or volume due to menstrual cycle symptoms compared to recreational athletes.

If you are a competitive strength athlete, you are statistically less likely to skip or reduce training due to menstrual symptoms than a recreational lifter. This is likely due to competitive drive. However, be aware that 69.5% of all participants still altered their programs, so monitor your fatigue and load to ensure you are not compromising long-term recovery or health.

Increased physical activity during GLP-1 RA therapy may help attenuate the medication-associated increase in resting heart rate, though this effect was not statistically significant in this study.

If you are experiencing an increased heart rate on GLP-1 medication, try to incorporate more physical activity. This study suggests that higher activity levels might help blunt this increase, although more research is needed to confirm this. Aim for any amount of movement, as even small increases (median split was <10 min/day) showed a trend toward benefit.

Pregnant women face significant modifiable barriers to physical activity, primarily intrapersonal factors (time constraints, fatigue, lack of motivation) and interpersonal factors (lack of healthcare provider advice), which can be addressed through targeted education and counseling.

Pregnant women in resource-limited settings should be counseled by healthcare providers on the safety and benefits of physical activity, specifically highlighting that walking and household chores count as exercise. Addressing fatigue through light activity and providing clear guidelines can overcome common barriers like lack of time and motivation.

Declines in lifestyle physical activity (LSPA/NEAT), driven by technological and environmental changes, are a primary contributor to the rising prevalence of obesity, whereas leisure-time physical activity (LTPA) has remained relatively stable.

Focus on increasing daily movement (walking, standing, chores) rather than relying solely on gym sessions. Small reductions in daily activity (e.g., using remote controls, driving instead of walking) accumulate to impact weight. To prevent obesity, integrate more movement into your daily routine (LSPA).

Targeted, governmentally supported physical activity interventions are more likely to be successful than global, non-specific interventions.

If implementing a physical activity program, tailor it to the specific local culture and environment (e.g., school-based for kids, workplace for adults) and secure government infrastructure support rather than using a generic global message.

Possession of the GLI3 rs10263647 T/T genotype prevents resistance training-induced increases in vastus lateralis muscle fiber cross-sectional area (fCSA), whereas T/C and C/C genotypes exhibit significant hypertrophy.

If you are a young man starting resistance training, your genetics (specifically the GLI3 gene) may dictate whether your muscle fibers actually increase in size. Those with the T/T genotype may not see muscle fiber growth despite training, while those with T/C or C/C genotypes will likely see significant growth. This is a biological filter, not a failure of effort.

The GLI3 rs10263647 T/T genotype is associated with a failure to increase satellite cell numbers and a failure to add myonuclei in response to resistance training, unlike T/C and C/C genotypes.

For young men with the GLI3 T/T genotype, resistance training may not trigger the cellular machinery (satellite cell addition and myonuclear accretion) typically required for muscle growth. This explains why some individuals do not see muscle fiber enlargement despite consistent effort.

Central obesity and increased total body fat are primary predictors of insulin resistance and the evolution of impaired glucose tolerance into frank diabetes, mediated by pro-inflammatory cytokines.

Focus on reducing central abdominal fat and overall body fat percentage, not just total body weight. Regular physical activity and dietary changes that improve body composition are crucial for preventing insulin resistance and type 2 diabetes, especially if you belong to high-risk ethnic groups or live in rapidly developing regions.

Probiotic supplementation has a regulatory effect on weight and BMI, with greater weight loss magnitude observed in populations with longer treatment durations.

If you are considering probiotics for weight management, look for strains with clinical evidence for obesity. The paper notes that longer treatment durations are associated with greater weight loss, suggesting consistency is key. It is not a quick fix but may support metabolic health over time.

Lifestyle interventions (diet and exercise) significantly improve sperm normal morphology and progressive motility in men with obesity, whereas bariatric surgery and pharmacotherapy (metformin/liraglutide) show no clinically significant improvements in semen parameters or DNA damage.

If you are overweight and trying to conceive, focus on sustainable lifestyle changes (diet and exercise) rather than seeking surgical or pharmacological weight loss solutions solely for fertility. Lifestyle changes have been shown to improve sperm morphology and motility, whereas surgery and weight-loss drugs have not shown consistent benefits for semen quality in this population.

Genetic variants in GLP1R (e.g., rs6923761), GIPR (e.g., rs2287019, rs10423928), and TCF7L2 (rs7903146) significantly influence individual response to tirzepatide, affecting glycemic control, weight loss, and side effect profiles.

Your genes can affect how well tirzepatide works for you. If you have certain genetic variants, you might need a different dose or might experience different side effects. Talk to your doctor about genetic testing to personalize your treatment.

Pre-pregnancy lifestyle interventions (dietary restriction or exercise) initiated at least 9 weeks prior to conception reduce the risk of metabolic-associated fatty liver disease (MAFLD) in offspring of obese mothers, whereas interventions initiated only 1 week prior do not.

If you have obesity and plan to conceive, starting weight management 9+ weeks before trying to get pregnant is critical for your future child's liver health. Standard lifestyle changes may take too long, so discuss pre-pregnancy pharmacotherapy (like GLP-1 agonists) with your doctor to ensure you reach a healthy weight before conception.

Pre-pregnancy use of GLP-1 receptor agonists (e.g., liraglutide) or GLP-1/GIP co-agonists (e.g., tirzepatide) is a promising pharmacotherapeutic strategy for pre-pregnancy weight loss in obese women, potentially mitigating the intergenerational risk of MAFLD in offspring, provided sufficient wash-out periods are observed.

If lifestyle changes aren't enough to help you reach a healthy weight before pregnancy, talk to your doctor about GLP-1 medications. They are effective for weight loss and may improve your future child's liver health. Crucially, you must stop these medications well before trying to conceive to ensure they are out of your system.

Among Japanese patients with type 2 diabetes, low intake of vegetables (specifically green-yellow and other vegetables) and high intake of sweets are the strongest dietary predictors of obesity, with these associations holding true across both men and women.

For Japanese patients with Type 2 Diabetes, managing obesity relies less on counting total calories and more on food quality. Prioritize increasing intake of green-yellow and other vegetables, as low vegetable intake is a strong predictor of obesity. Simultaneously, reduce sweets. If you consume sweets, ensure you are also eating a median amount of fruit, which may mitigate the obesity risk, but do not exceed median sweets intake even with high fruit consumption.

Combining low intake of total vegetables with low intake of fruits creates a synergistic effect that significantly increases the odds of obesity, with the highest risk observed when both are in the lowest quartiles.

Do not skip fruits. The highest risk for obesity occurs when you eat very few vegetables AND very few fruits. Eating both in adequate amounts (top quartiles) offers the strongest protection against obesity.

N-of-1 study designs provide a higher level of evidence for determining individualized treatment efficacy in medical nutrition therapy compared to traditional Randomized Controlled Trials (RCTs), which often mask individual variance through mean effect sizes.

If you are a dietitian, standard RCT-based guidelines may not work for every patient because individual responses vary widely. To practice true precision nutrition, consider using N-of-1 trial designs (testing one patient against themselves with multiple diet phases) to identify the specific dietary pattern that works for that individual's biology and lifestyle, rather than relying solely on population averages.